Search Results

You are looking at 41 - 50 of 120 items for :

  • "prognostic factor" x
  • Refine by Access: All content x
Clear All
Open access

Kazhan Mollazadegan, Britt Skogseid, Johan Botling, Tobias Åkerström, Barbro Eriksson, Staffan Welin, Anders Sundin, and Joakim Crona

-like features as a biomarker of treatment success, as data were only available in some patients. While NEC-like features were not a prognostic factor in our previous study, it is possible that these patients may respond differently to systemic treatments as

Open access

Jiaxin Luo, Weili Yin, Qiuxia Lin, Juqing Wu, Pan Chen, Yuanna Ling, Jing Wang, Zhen Li, Liqin Pan, Yanying Chen, Wei Ouyang, and Huijuan Feng

metastasis . Journal of Clinical Oncology 2005 23 4821 – 4822 . ( ) 10.1200/JCO.2005.02.911 10 Orita Y Sugitani I Matsuura M Ushijima M Tsukahara K Fujimoto Y Kawabata K . Prognostic factors and the

Open access

Joana Simões-Pereira, Daniel Macedo, and Maria João Bugalho

. Performance status was considered by Henriques de Figueiredo and coworkers ( 18 ) as an important prognostic factor in patients with brain metastases from thyroid cancer. These authors verified an overall survival of 27 months when patients’ PS was <2 and 3

Open access

Jülide Durmuşoğlu, Henri J L M Timmers, Pepijn van Houten, Johan F Langenhuijsen, Ad R M M Hermus, and Annenienke C van de Ven

DJ , Winchester DJ , Kebebew E & Sturgeon C . Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors . Cancer 2008 113 3130 – 3136 . ( ) 7 Libé R , Borget

Open access

Thomas Couronne, Paul Girot, Julien Hadoux, Thierry Lecomte, Alice Durand, Caroline Fine, Katia Vandevoorde, Catherine Lombard-Bohas, and Thomas Walter

symptomatic patients. Of note, the present study did not include a control group without treatment, preventing us to distinguish prognostic vs predictive factors. Bone metastasis is certainly more a prognostic factor as already reported ( 16 ), rather than a

Open access

Huy Gia Vuong, Nguyen Phuoc Long, Nguyen Hoang Anh, Tran Diem Nghi, Mai Van Hieu, Le Phi Hung, Tadao Nakazawa, Ryohei Katoh, and Tetsuo Kondo

increased risk for all adverse prognostic factors when compared to classical PTC, except tumor recurrence and patient mortality due to lack of data ( Fig. 3 and Table 2 ). The meta-analyses were consistent among all included studies. Only a small amount of

Open access

Matilde Calanchini, Michael Tadman, Jesper Krogh, Andrea Fabbri, Ashley Grossman, and Brian Shine

reference method for plotting the ROC curve analysis, we found that the spot urinary 5-HIAA has excellent favourable accuracy characteristics, although in general urinary 5-HIAA is not an entirely reliable prognostic factor ( 28 , 29 , 30 , 31 , 32

Open access

S C Clement, W E Visser, C A Lebbink, D Albano, H L Claahsen-van der Grinten, A Czarniecka, R P Dias, M P Dierselhuis, I Dzivite-Krisane, R Elisei, A Garcia-Burillo, L Izatt, C Kanaka-Gantenbein, H Krude, L Lamartina, K Lorenz, M Luster, R Navardauskaitė, M Negre Busó, K Newbold, R P Peeters, G Pellegriti, A Piccardo, A L Priego, A Redlich, L de Sanctis, M Sobrinho-Simões, A S P van Trotsenburg, F A Verburg, M Vriens, T P Links, S F Ahmed, and H M van Santen

Redlich A Luster M Lorenz K Lessel L Rohrer TR Schmid KW Frühwald MC Vorwerk P Kuhlen M . Age, American Thyroid Association Risk Group, and Response to Therapy Are Prognostic Factors in Children With Differentiated Thyroid Cancer

Open access

Jes Sloth Mathiesen, Jens Peter Kroustrup, Peter Vestergaard, Per Løgstrup Poulsen, Åse Krogh Rasmussen, Ulla Feldt-Rasmussen, Sten Schytte, Stefano Christian Londero, Henrik Baymler Pedersen, Christoffer Holst Hahn, Jens Bentzen, Sören Möller, Mette Gaustadnes, Maria Rossing, Finn Cilius Nielsen, Kim Brixen, Christian Godballe, and Danish Thyroid Cancer Group (DATHYRCA)

-Devolx B Maes B Boneu A Schlumberger M Bigorgne JC Dumontier P Leclerc L , et al . Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d’Etude des Tumeurs a

Open access

Josi Vidart, Paula Jaskulski, Ana Laura Kunzler, Rafael Aguiar Marschner, André Ferreira de Azeredo da Silva, and Simone Magagnin Wajner

is the prevalence of NTIS? Is NTIS associated with adverse clinical outcome? Eligibility criteria We included only cohort studies (either prospective or retrospective) and clinical trials which analyzed NTIS as a prognostic factor in